Voveran SR 75 Tablet (10)

 8728 people have bought this recently
10 Tablet in 1 Strip
₹ 95.8 ₹112.7 15% OFF Save: ₹17
10 TABLET 1 Strip ₹ 95.8 ₹112.7 15% OFF Save: ₹17

  • Seller: mChemist Global Private Limited
    • Free Shipping Available
       
    • Country of Origin: India

    Voveran SR 75 Tablet (10)

    10 Tablet in 1 Strip
    ₹ 95 ₹112 15% OFF Save: ₹17
    10 TABLET | 1 Strip
    ₹ 95 ₹112 15% OFF Save: ₹17
    8728 people have bought this recently
  • Seller: mChemist Global Private Limited
    • Free Shipping Available
       
    • Country of Origin: India

    Frequently Bought Together

    Frequently Bought Together



    Voveran SR 75 Tablet (10) Information

    Voveran SR 75 Tablet (10) is a prescription drug, available for use as Tablet. It is primarily used for the treatment of Muscle Pain, Toothache, Rheumatic Pain. Secondary and off-label uses of Voveran SR 75 Tablet (10) have also been mentioned below.

    The correct dosage of Voveran SR 75 Tablet (10) depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. This information has been provided in detail in the dosage section.

    While these are the most often observed Voveran SR 75 Tablet (10) side effects, there are can be others also. These have been listed below. These side effects of Voveran SR 75 Tablet (10) are usually temporary and subside with the completion of treatment. Please speak with your doctor if these side effects worsen or persist for a longer duration.

    Furthermore, you should know that effect of Voveran SR 75 Tablet (10) is Severe for pregnant women and Mild for women who are breastfeeding. It is important to know if Voveran SR 75 Tablet (10) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Voveran SR 75 Tablet (10) related warnings section.

    Voveran SR 75 Tablet (10) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Voveran SR 75 Tablet (10) in conditions like Stomach Infection, Skin Rash, Stroke. Other contraindications of Voveran SR 75 Tablet (10) have been discussed in the sections ahead.

    Drug interactions for Voveran SR 75 Tablet (10) have been reported in the medical literature. A complete list of these interactions is given below.

    In addition to the above precautions for Voveran SR 75 Tablet (10), it is important to know that it is safe while driving, and is habit-forming.



    Voveran SR 75 Tablet (10) Benefits & Uses

    Voveran SR 75 Tablet (10) is used to treat the following -

    Main Benefits

    Other Benefits

    Voveran SR 75 Tablet (10) Dosage & How to Take

    This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

    Find the right dosage based on disease and age

    Age Group Dosage
    Adult
    • Disease:
    • Before or After Meal: After Meal
    • Single Maximum Dose: 50 mg
    • Dosage Form: Tablet (Immediate Release)
    • Dosage Route: Oral
    • Frequency: 3 daily
    • Course Duration: As directed by the doctor
    • Special Instructions: As prescribed by the doctor
    Geriatric
    • Disease:
    • Before or After Meal: After Meal
    • Single Maximum Dose: 50 mg
    • Dosage Form: Tablet (Immediate Release)
    • Dosage Route: Oral
    • Frequency: 3 daily
    • Course Duration: As directed by the doctor
    • Special Instructions: As prescribed by the doctor


    Voveran SR 75 Tablet (10) Side Effects

    Based on research, the following side effects have been observed when Voveran SR 75 Tablet (10) is used -

    Severe

    Moderate

    • Fluid Retention
    • पेट दर्द
    • Arrhythimia

    Mild

    Voveran SR 75 Tablet (10) Related Warnings

    • Is the use of Voveran SR 75 Tablet (10) safe for pregnant women?


      Pregnant women may get severe side effects after taking Voveran. If you are pregnant, do not take Voveran without a doctor's advice.

      Severe
    • Is the use of Voveran SR 75 Tablet (10) safe during breastfeeding?


      Voveran may have very limited harmful effects for breastfeeding women.

      Mild
    • What is the effect of Voveran SR 75 Tablet (10) on the Kidneys?


      There may be some severe side effects of Voveran on your kidney. Do not take it unless a doctor says so.

      Severe
    • What is the effect of Voveran SR 75 Tablet (10) on the Liver?


      Voveran can cause side effects that could harm the liver. So medical advice before taking it is necessary.

      Severe
    • What is the effect of Voveran SR 75 Tablet (10) on the Heart?


      Voveran may cause harmful effects on the heart. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.

      Moderate


    Severe Interaction of Voveran SR 75 Tablet (10) with Other Drugs

    Voveran SR 75 Tablet (10) should not be taken with following medicines due to severe side effects it may cause to patients -

    Severe

    Moderate



    Voveran SR 75 Tablet (10) Contraindications

    If you are suffering from any of the following diseases, you should not take Voveran SR 75 Tablet (10) unless your doctor advises you to do so -



    Frequently asked Questions about Voveran SR 75 Tablet (10)

    • Is this Voveran SR 75 Tablet (10) habit forming or addictive?


      Forming a habit of Voveran SR 75 Tablet (10) has not been reported.

      No
    • Is it safe to drive or operate heavy machinery when consuming?


      Yes, you can comfortably use machinery or drive after taking Voveran SR 75 Tablet (10) since it will not make you feel sleepy.

      Safe
    • Is it safe?


      Yes, but take Voveran SR 75 Tablet (10) only as per medical advice.

      Safe, but take only on Doctor's advise
    • Is it able to treat mental disorders?


      No, Voveran SR 75 Tablet (10) is not used to treat mental disorders.

      No

    Voveran SR 75 Tablet (10) Interactions with Food and Alcohol

    • Interaction between Food and Voveran SR 75 Tablet (10)


      There isn't any research available on the side effects of taking Voveran SR 75 Tablet (10) with food.

      Unknown
    • Interaction between Alcohol and Voveran SR 75 Tablet (10)


      Taking Voveran SR 75 Tablet (10) with alcohol can have severely harmful effects on your health.

      Severe


    See all substitutes for Voveran



    This medicine data has been created by -

    Vikas Chauhan

    B.Pharma, Pharmacy
    7 Years of Experience



    References

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 427-429

    KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 204

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Voltaren® (diclofenac sodium)

    US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Diclofenac (diclofenac sodium)

    Therapeutic Goods Administration (TGA): Department of Health [Internet]. Governmet of Australia; Package leaflet information for the user; Solaraze® (diclofenac sodium)

    Ayurvedic Alternatives from myUpchar Ayurveda

    Joint Support Tablet 60 Tablet in 1 Bottle ₹499 ₹69528% off
    Calcium Magnesium Zinc With Vitamin D3 120 Tablet in 1 Bottle ₹449 ₹74940% off
    Nimbadi Churna 60 Tablet in 1 Bottle ₹399 ₹45011% off
    Joint Capsule 60 Capsule in 1 Bottle ₹716 ₹79910% off
    Joint Pain Oil 100 ml Oil in 1 Bottle ₹329 ₹54940% off
    See more


    In stock alternatives of Voveran (based on Diclofenac (75 mg))

    TABLET
    TABLET
    TABLET
    TABLET
    TABLET
    TABLET


    You may also like

    Pletoz 50 Tablet
    Pletoz 50 Tablet 10 Tablet in 1 Strip ₹168 ₹19714% off
    Dynapar SR 100 Tablet
    Dynapar SR 100 Tablet 10 Tablet in 1 Strip ₹116 ₹13614% off
    Voveran SR 100 Tablet (15)
    Voveran SR 100 Tablet (15) 15 Tablet in 1 Strip ₹202 ₹23714% off
    Retoz MR 8 Tablet
    Retoz MR 8 Tablet 10 Tablet in 1 Strip ₹431 ₹49513% off
    Neorelax MR Tablet
    Neorelax MR Tablet 10 Tablet in 1 Strip ₹315 ₹37014% off
    Diclomol Tablet
    Diclomol Tablet 10 Tablet in 1 Strip ₹96 ₹11214% off